Quantum Phar. Share Discussion Threads

[busterdog2] 19/8/2016 16:39

Not me, but they do seem to be getting their act together. And the progression of the share price is a reflection of that.

[werewolfie] 19/8/2016 16:36

Great finish today! Now - does anyone know of further product launches which help maintain the momentum?

[busterdog2] 19/8/2016 16:25

We have lift off!!!

[mfhmfh] 19/8/2016 08:49

touched 80p this morning

[hazl] 19/8/2016 07:08

yes you are correct werewolf imo

I daresay the change of CEO may be perceived to be as well,though I expect that Andrew did a good enough job at the time.

[werewolfie] 18/8/2016 23:18

Excuse me? I think it is. Don't be dismissive with someone who asks a valid question.The delay in launching products caused the share price to slump. More product launches in the future will attract positive attention to this niche company

[r ball] 18/8/2016 21:22

Not material. CEO important.

[werewolfie] 18/8/2016 20:01

I'm happy to hear about the new product launches. Especially as I bought in at 1.30 and was dismayed to see it slump to 51p

Anyone know which products still have to be launched?

[lanzarote666] 17/8/2016 13:01

Have appointed their first corporate communications manager;



My understanding is that the fall in the share price was due to over-promising new products which were delayed and are now only coming to market.

It appears that they are keen to start raising their profile and with more product news expected this could prove promising.

Profitable and the opportunity for growth.

I agree that the chart does look indicative of an increase from here, so may be worth an interest for me. NAI DYOR

[r ball] 17/8/2016 12:47

Dear Mr Ball

Many thanks for your email.

We will be issuing a trading update in the not too distant future however, we are not able to confirm a date.

In the meantime, I attach a link to our AGM statement for your information:

hxxp://ir.quantumpharmagroup.com/content/news/news_archive/2016/12-07-16.asp

Kind regards
Phillipa

Phillipa O’Sullivan
Executive Assistant / Corporate Communications Executive
Email: phillipa.o’[e-mail]

[mfhmfh] 17/8/2016 10:37

I e-mailed the company last week asking when the trading update is (was on 20th August last year).

I received a reply stating 'we will be issuing a trading update in the not too distant future however, we are not able to confirm a date.'

[busterdog2] 16/8/2016 17:18

A decent trading statement in the next week or so and with luck we should see a re rating.

[haroldthegreat] 11/8/2016 11:18

Glycopyrronium also used in PD and MND.current price paid by NHS for 100mls is £102.79.for a special formulation.1mg/5ml

[bigdazzler] 11/8/2016 10:54

Had a little buy in these. I like the look of the chart and I like the look of the company financials.

[hazl] 10/8/2016 10:51

lovely bowl on chart imo

[busterdog2] 05/8/2016 15:54

Yes, these things don't happen overnight.

[rosejs2] 05/8/2016 12:56

These Cancer related products appear to offer solutions to currently unmet needs..
If this is the case why are QP not establishing a core of international partners to promote these products 'Globally'...The fact that these products have been approved by one of the most demanding approval bodies in the UK should help them pass other territory opportunities...The same logic applies to many other of the QP portfolio .. creating multiple revenue streams and hence additional profits for shareholders..Am I missing something?

[mfhmfh] 05/8/2016 11:56

another product launched. are these products any good?

This from the RNS on 19.01.16:

'As part of this review, external consultants were engaged to assess the value and market potential of the regulated product pipeline. The Board is pleased to report that its prior assessments of the value of the pipeline, which has more than doubled in size since the Group was admitted to AIM, have been reaffirmed.'

Sounds positive if external consultants have reaffirmed the value of the pipeline.

Also, unfortunately, cancer sufferers will need these medications long-term for their symptoms so GPs will be giving them as 'repeat prescriptions' which will increase volume of sales.

IMHO